Literature DB >> 24508032

Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups.

David Vivas-Consuelo1, Ruth Usó-Talamantes2, José Luis Trillo-Mata2, Maria Caballer-Tarazona3, Isabel Barrachina-Martínez4, Laia Buigues-Pastor4.   

Abstract

BACKGROUND: Risk adjustment instruments applied to existing electronic health records and administrative datasets may contribute to monitoring the correct prescribing of medicines.
OBJECTIVE: We aim to test the suitability of the model based on the CRG system and obtain specific adjusted weights for determined health states through a predictive model of pharmaceutical expenditure in primary health care.
METHODS: A database of 261,054 population in one health district of an Eastern region of Spain was used. The predictive power of two models was compared. The first model (ATC-model) used nine dummy variables: sex and 8 groups from 1 to 8 or more chronic conditions while in the second model (CRG-model) we include sex and 8 dummy variables for health core statuses 2-9.
RESULTS: The two models achieved similar levels of explanation. However, the CRG system offers higher clinical significance and higher operational utility in a real context, as it offers richer and more updated information on patients.
CONCLUSIONS: The potential of the CRG model developed compared to ATC codes lies in its capacity to stratify the population according to specific chronic conditions of the patients, allowing us to know the degree of severity of a patient or group of patients, predict their pharmaceutical cost and establish specific programmes for their treatment.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Clinical Risk Groups; Pharmacy expenditure; Risk adjustment; WHO-ATC-Code

Mesh:

Year:  2014        PMID: 24508032     DOI: 10.1016/j.healthpol.2014.01.012

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  11 in total

1.  Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool.

Authors:  David Vivas-Consuelo; Ruth Usó-Talamantes; Natividad Guadalajara-Olmeda; José-Luis Trillo-Mata; Carla Sancho-Mestre; Laia Buigues-Pastor
Journal:  BMC Health Serv Res       Date:  2014-10-21       Impact factor: 2.655

2.  Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data.

Authors:  Carla Sancho-Mestre; David Vivas-Consuelo; Luis Alvis-Estrada; Martin Romero; Ruth Usó-Talamantes; Vicent Caballer-Tarazona
Journal:  BMC Health Serv Res       Date:  2016-08-17       Impact factor: 2.655

3.  [Adjusted morbidity groups: A pending debate].

Authors:  Jose M Inoriza; M Carreras; X Pérez-Berruezo; J Coderch
Journal:  Aten Primaria       Date:  2017-04-05       Impact factor: 1.137

4.  [Author's reply to letter 'Adjusted morbidity groups: A pending debate'].

Authors:  David Monterde; Emili Vela; Montse Clèries
Journal:  Aten Primaria       Date:  2017-07-08       Impact factor: 1.137

5.  [Morbidity observed in a health area: Impact on professionals and funding].

Authors:  Pablo de Miguel; Isabel Caballero; Francisco Javier Rivas; Jaime Manera; María Auxiliadora de Vicente; Ángel Gómez
Journal:  Aten Primaria       Date:  2014-10-23       Impact factor: 1.137

6.  Variability in Healthcare Expenditure According to the Stratification of Adjusted Morbidity Groups in the Canary Islands (Spain).

Authors:  Maria Consuelo Company-Sancho; Víctor M González-Chordá; María Isabel Orts-Cortés
Journal:  Int J Environ Res Public Health       Date:  2022-04-01       Impact factor: 3.390

7.  A cost and performance comparison of Public Private Partnership and public hospitals in Spain.

Authors:  Maria Caballer-Tarazona; Antonio Clemente-Collado; David Vivas-Consuelo
Journal:  Health Econ Rev       Date:  2016-05-14

8.  Factors influencing the variation in GMS prescribing expenditure in Ireland.

Authors:  A ConwayLenihan; S Ahern; S Moore; J Cronin; N Woods
Journal:  Health Econ Rev       Date:  2016-03-29

9.  [Impact of cardiovascular risk factors on the consumption of resources in Primary Care according to Clinical Risk Groups].

Authors:  Magdalena Millá Perseguer; Natividad Guadalajara Olmeda; David Vivas Consuelo
Journal:  Aten Primaria       Date:  2018-06-13       Impact factor: 1.137

Review 10.  A systematic review of risk stratification tools internationally used in primary care settings.

Authors:  Shelley-Ann M Girwar; Robert Jabroer; Marta Fiocco; Stephen P Sutch; Mattijs E Numans; Marc A Bruijnzeels
Journal:  Health Sci Rep       Date:  2021-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.